Holen Sie sich die Stockscreener-App
19.33
0.51%
-0.10
Handel nachbörslich:
19.33
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt KVUE?
Forum
Prognose
Dividendenhistorie
Schlusskurs vom Vortag:
$19.43
Offen:
$19.28
24-Stunden-Volumen:
20.41M
Relative Volume:
1.03
Marktkapitalisierung:
$37.13B
Einnahmen:
$15.29B
Nettoeinkommen (Verlust:
$1.62B
KGV:
22.92
EPS:
0.8433
Netto-Cashflow:
$1.82B
1W Leistung:
+2.82%
1M Leistung:
+0.26%
6M Leistung:
+2.98%
1J Leistung:
-8.78%
1-Tages-Spanne:
$19.18
$19.38
1-Wochen-Bereich:
$18.87
$19.56
52-Wochen-Spanne:
$14.02
$21.40
Kenvue Inc Stock (KVUE) Company Profile
Firmenname
Kenvue Inc
Sektor
Telefon
908-874-1200
Adresse
1 KENVUE WAY, SUMMIT
Compare KVUE vs PG, UL, CL, EL
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
KVUE
Kenvue Inc
|
19.33 | 36.36B | 15.29B | 1.62B | 1.82B | 0.8433 |
PG
Procter Gamble Co
|
145.40 | 332.32B | 86.72B | 16.69B | 15.03B | 6.8375 |
UL
Unilever Plc Adr
|
65.15 | 136.52B | 56.67B | 6.96B | 7.39B | 3.1265 |
CL
Colgate Palmolive Co
|
91.33 | 71.51B | 20.80B | 2.22B | 3.77B | 2.5772 |
EL
Estee Lauder Cos Inc
|
104.85 | 34.79B | 14.85B | -248.00M | 1.29B | -0.6966 |
Kenvue Inc Stock (KVUE) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-30 | Herabstufung | Jefferies | Buy → Hold |
| 2025-10-29 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2025-09-26 | Hochstufung | Rothschild & Co Redburn | Neutral → Buy |
| 2025-04-10 | Eingeleitet | Redburn Atlantic | Neutral |
| 2025-03-24 | Eingeleitet | Evercore ISI | In-line |
| 2025-01-06 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2024-12-12 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2024-09-24 | Eingeleitet | Jefferies | Buy |
| 2024-09-24 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2024-05-28 | Fortgesetzt | Citigroup | Neutral |
| 2024-04-11 | Eingeleitet | Bernstein | Underperform |
| 2024-04-03 | Eingeleitet | William Blair | Mkt Perform |
| 2024-03-01 | Fortgesetzt | Goldman | Neutral |
| 2023-11-17 | Eingeleitet | Piper Sandler | Neutral |
| 2023-09-11 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2023-09-07 | Eingeleitet | Canaccord Genuity | Buy |
| 2023-09-06 | Eingeleitet | Argus | Hold |
| 2023-08-24 | Hochstufung | Goldman | Neutral → Buy |
| 2023-07-25 | Eingeleitet | Edward Jones | Buy |
| 2023-06-01 | Eingeleitet | HSBC Securities | Hold |
| 2023-05-30 | Eingeleitet | BofA Securities | Buy |
| 2023-05-30 | Eingeleitet | Citigroup | Neutral |
| 2023-05-30 | Eingeleitet | Deutsche Bank | Hold |
| 2023-05-30 | Eingeleitet | Exane BNP Paribas | Neutral |
| 2023-05-30 | Eingeleitet | Goldman | Neutral |
| 2023-05-30 | Eingeleitet | JP Morgan | Overweight |
| 2023-05-30 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2023-05-30 | Eingeleitet | UBS | Neutral |
Alle ansehen
Kenvue Inc Aktie (KVUE) Neueste Nachrichten
Essity to acquire Kenvue"s feminine care business in Brazil for $284 million - lesprom.com
Colgate-Palmolive India Taps Kenvue's Manish Anandani as Next CEO - finance.biggo.com
Kenvue stock holds near $19 after Brazil deal headlines - Ad-hoc-news.de
Colgate-Palmolive India Taps A Kenvue Exec As CEO - Finimize
Essity To Acquire Kenvue’s Brazil Feminine Care Business For $284 Million - Pulse 2.0
Colgate Palmolive India Appoints Kenvue Executive As MD And CEO - ESM Magazine
Danske Bank A S Purchases New Holdings in Kenvue Inc. $KVUE - MarketBeat
Great Lakes Advisors LLC Makes New $3.52 Million Investment in Kenvue Inc. $KVUE - MarketBeat
253,882 Shares in Kenvue Inc. $KVUE Purchased by Advisors Capital Management LLC - MarketBeat
Kenvue (KVUE) Stock Looks Cheap On Cash Flow But Fair On Earnings - Yahoo Finance
Colgate Palmolive India appoints Kenvue exec as MD and CEO - Business Standard
Colgate Palmolive India nomina un dirigente di Kenvue come amministratore delegato e CEO - TradingView
Colgate Palmolive India appoints Kenvue exec Manish Anandani as MD and CEO - The Economic Times
Essity To Acquire Kenvue’s Brazil Feminine Care Portfolio For $284M - Femtech Insider
Kenvue stock holds around $19 as Brazil feminine care sale and Kimberly-Clark deal reshape outlook - Ad-hoc-news.de
Essity buys Kenvue Brazilian feminine care business in US$284M deal - Personal Care Insights
Essity to Acquire Kenvue's Feminine Care Business in Brazil for $284 Million - paperage.com
Kenvue (KVUE) Stock Looks Reasonable Despite A 37% Fair Value Gap - simplywall.st
Kenvue (KVUE) Launches Zyrtec Spray As Its Undervalued Case Faces A Fresh Test - Yahoo Finance UK
Essity to buy Kenvue’s feminine care brands in Brazil for $284m - Valor International
Kimberly-Clark prepares US$1.9 billion reorganization through synergies following Kenvue acquisition - Tissue Online North America
Tocqueville Asset Management L.P. Makes New $30.30 Million Investment in Kenvue Inc. $KVUE - MarketBeat
Meeder Advisory Services Inc. Makes New $1.17 Million Investment in Kenvue Inc. $KVUE - MarketBeat
Kimberly-Clark stock trades at a discount as Kenvue deal reshapes the outlook - Investing.com
Essity to acquire Kenvue’s feminine care business in Brazil - METissue
Edmond DE Rothschild Holding S.A. Takes Position in Kenvue Inc. $KVUE - MarketBeat
Deutsche Bank AG Makes New Investment in Kenvue Inc. $KVUE - MarketBeat
Beyond the backlash: What the Neutrogena controversy says about long-term brand loyalty - Modern Retail
Neutrogena Parent Stock Takes a Hit Amid Hayden Panettiere Backlash - Complex
Kenvue to Sell Feminine Care Business in Brazil to Essity - marketscreener.com
Essity to buy Kenvue's feminine care business in Brazil for $284 million - marketscreener.com
Kimberly-Clark Looks Undervalued Ahead of Transformative Kenvue Deal, Analysts Say - Investing.com
Kimberly-Clark's purchase of Kenvue sees in-depth China reviewreport - Seeking Alpha
Neutrogena Stock Slips After Outrage Over Hayden Panettiere’s Alleged Firing Following Her Death - Yahoo! Finance Canada
Mitsubishi UFJ Asset Management Co. Ltd. Takes $96.09 Million Position in Kenvue Inc. $KVUE - MarketBeat
Greenland Capital Management LP Takes $3.84 Million Position in Kenvue Inc. $KVUE - MarketBeat
73,621 Shares in Kenvue Inc. $KVUE Bought by Commerzbank Aktiengesellschaft FI - MarketBeat
7,600,073 Shares in Kenvue Inc. $KVUE Bought by Equity Investment Corp - MarketBeat
BlackRock Inc. Purchases Shares of 150,825,694 Kenvue Inc. $KVUE - MarketBeat
Kimberly-Clark/Kenvue: Deal That Would Create Consumer Goods Giant Enters Phase 2 Review in China; SAMR Minister Vacancy Could Figure into Delays on Merger Investigations - The Capitol Forum
Kenvue stock holds steady as dividend yield and Q2 growth support cautious outlook - Ad-hoc-news.de
Zyrtec debuts Allergen Shield Spray, rewrites allergy treatment - Medical Marketing and Media
Neutrogena’s stock spirals after Hayden Panettiere’s tragic death as fans vow to boycott: ‘I will never buy again’ - New York Post
Mondelez Appoints Kenvue Alum Banati CFO - Moomoo
Should Kenvue’s (KVUE) Stronger Q2 2026 Earnings Shift Investors’ View of Its Profitability Story? - Sahm
ZYRTEC® Launches New Drug-Free Allergen Shield Spray, a Breakthrough for Proactive Everyday* Allergen Defense - PR Newswire
Nuance Investments LLC Buys Shares of 1,448,488 Kenvue Inc. $KVUE - MarketBeat
NINE MASTS CAPITAL Ltd Takes $20.26 Million Position in Kenvue Inc. $KVUE - MarketBeat
Plato Investment Management Ltd Invests $1.30 Million in Kenvue Inc. $KVUE - MarketBeat
Kenvue Shares Drop 2.1% While Deal Calculations Account for 88% of Decline in Tylenol Maker - TechStock²
B & T Capital Management DBA Alpha Capital Management Makes New Investment in Kenvue Inc. $KVUE - MarketBeat
Finanzdaten der Kenvue Inc-Aktie (KVUE)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.31%
0.69%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):